title: Targeting triglycerides in secondary prevention: should we bother?
authors.affiliation: Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.
authors.forename: V G
authors.initials: VG
authors.lastname: Athyros
authors.forename: A I
authors.initials: AI
authors.lastname: Kakafika
authors.forename: A S
authors.initials: AS
authors.lastname: Wierzbicki
authors.forename: A
authors.initials: A
authors.lastname: Karagiannis
authors.forename: D P
authors.initials: DP
authors.lastname: Mikhailidis
mesh_terms: D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D004812:Epidemiologic Methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D055502:Secondary Prevention; D014280:Triglycerides / Q000097:blood*
chemical_list: D000924:Anticholesteremic Agents; D014280:Triglycerides